What Happens If You Ship a Medical Device to the U.S. Without a Required 510(k)?

For international medical device manufacturers, shipping a product to the United States can feel like the final step in entering the U.S. market.

From FDA’s perspective, however, importation is also a compliance checkpoint.

Before a medical device is admitted into U.S. commerce, FDA may verify whether the manufacturer, device, and importer meet applicable regulatory requirements. When a device requires premarket authorization — including a 510(k) — attempting to import the product before satisfying that requirement can create significant regulatory and commercial problems.

This is particularly important for foreign manufacturers that assume FDA establishment registration or device listing alone allows a product to enter the United States.

It does not.

First: Not Every Medical Device Requires a 510(k)

A 510(k) is not required for every medical device sold in the United States.

The regulatory pathway depends on the device classification, intended use, applicable regulation, and whether the product qualifies for an exemption.

Depending on the device, the applicable pathway may include:

• 510(k) Premarket Notification

• De Novo classification

• Premarket Approval (PMA)

• An applicable exemption from premarket notification

FDA specifically advises companies to use its Product Classification Database to determine whether a device may require a 510(k) or PMA.

Therefore, the first question should never simply be:

“Do we need a 510(k)?”

The better question is:

“How is this specific device classified, and what FDA requirements apply to it before U.S. marketing?”

What Does FDA Check When a Medical Device Arrives in the United States?

FDA states that, at importation, it may verify compliance with requirements including:

• Establishment registration

• Device listing

• Applicable premarket submission requirements

• Labeling requirements

• Whether the manufacturer or product is subject to an Import Alert

FDA entry reviewers use information submitted with the import entry and compare it with FDA databases, including CDRH registration and listing information. If the information does not match, FDA may seek additional information or detain the product. If required registration and listing are missing, the product may ultimately be refused admission.

This means that regulatory preparation should occur before the shipment leaves the manufacturing country — not after the product reaches a U.S. port.

Import Alert 89-08: Devices Without Required Premarket Authorization

One of the most relevant FDA enforcement tools in this area is Import Alert 89-08.

The current alert is titled:

“Detention Without Physical Examination of Devices without Approved PMA's or IDE's and Other Devices Not Substantially Equivalent or Without a 510(k)”

FDA states that devices on the Red List may include devices for which a required 510(k) has not been filed and/or determined substantially equivalent, Class III devices without the required PMA, or investigational devices lacking an applicable IDE.

Import Alert 89-08 uses Detention Without Physical Examination, commonly referred to as DWPE.

This is important because DWPE allows FDA to detain covered shipments without first physically examining each shipment.

For certain devices lacking the appropriate 510(k) status, FDA identifies an import charge of:

NO 510(K) 

This does not mean that every shipment of every device lacking a 510(k) will automatically be placed on Import Alert 89-08. Import Alert status involves specific firms and/or products and FDA enforcement processes.

However, it demonstrates clearly that lack of required premarket authorization can become an import enforcement issue — not merely a paperwork problem.

Registration and Listing Are Not the Same as FDA Market Authorization

This is one of the most common areas of confusion for foreign manufacturers.

FDA establishment registration and medical device listing are important requirements, but they serve a different regulatory purpose from 510(k) clearance.

FDA explains that establishments generally must register and list the devices associated with their operations. Where a device requires marketing authorization before U.S. marketing, the owner/operator should also provide the applicable premarket submission number, such as a 510(k), De Novo, PMA, PDP, or HDE.

In practical terms:

FDA Registration ≠ FDA Approval or Clearance

and

Device Listing ≠ 510(k) Clearance

A manufacturer may therefore have an FDA registration number and still have a device that cannot legally be commercially marketed in the United States because the required premarket pathway has not been completed.

Registration and Listing Can Create Separate Import Risks

Premarket authorization is also not the only issue FDA checks.

FDA currently maintains Import Alert 99-34, covering drugs or medical devices from firms without valid registration and/or listing. FDA explains that establishments involved in the production and distribution of medical devices distributed in or imported into the United States are subject to applicable annual registration and product listing requirements.

This means a foreign manufacturer can face separate compliance problems involving:

1. The device’s market authorization status; and

2. The establishment’s registration and device listing status.

Both should be addressed before commercial importation.

Foreign Manufacturers Have Additional FDA Responsibilities

Foreign medical device manufacturers must satisfy applicable U.S. requirements before importing devices into the United States.

FDA identifies basic regulatory requirements that may include:

• Establishment registration

• Medical device listing

• Quality Management System requirements

• 510(k), unless exempt, or other applicable premarket authorization

• Labeling

• Medical Device Reporting requirements

Foreign manufacturers must also designate a U.S. Agent as part of their establishment registration.

Depending on the distribution structure, an Initial Importer may also have regulatory responsibilities under FDA requirements.

These roles should not be confused with the 510(k) itself. A U.S. Agent, Initial Importer, registration, or device listing does not compensate for missing premarket authorization where that authorization is required.

What Can Happen When a Shipment Is Detained?

When FDA identifies a compliance issue at importation, the consequences can extend beyond the individual shipment.

A detention can create:

• Delays at the port of entry

• Storage and logistics costs

• Requests for additional regulatory documentation

• Disruption of distributor or customer delivery schedules

• Potential refusal of admission

• Greater scrutiny of future shipments

If a firm or product is placed under DWPE through an Import Alert, resolving the issue can require substantially more work than addressing the regulatory pathway before the first shipment.

For Import Alert 89-08, FDA specifically provides a process through which a firm or its representative may submit supporting information seeking removal from DWPE.

That is a very different situation from simply preparing a compliant market-entry strategy in advance.

The Better Approach: Determine FDA Requirements Before Shipping

For a foreign manufacturer, a more appropriate sequence for U.S. market entry is:

Step 1 — Determine whether the product is a medical device in the United States.

The regulatory status assigned in another country does not automatically determine FDA classification.

Step 2 — Identify the FDA classification and product code.

The classification helps determine the applicable regulatory controls.

Step 3 — Determine the premarket pathway.

Confirm whether the device is 510(k)-exempt, requires a 510(k), or falls under another pathway such as De Novo or PMA.

Step 4 — Complete required premarket authorization before commercial distribution.

If a 510(k) is required, FDA clearance should be obtained before commercially marketing the device in the United States.

Step 5 — Complete applicable establishment registration and device listing requirements.

For foreign establishments, this also includes designating a U.S. Agent.

Step 6 — Confirm the U.S. import structure.

Review the manufacturer, importer, Initial Importer, product listing, labeling, and entry information before the first commercial shipment.

Step 7 — Ship only after the regulatory pathway is aligned.

This significantly reduces the risk of discovering a fundamental FDA issue after the product has already reached the U.S. border.

Common and Costly Misunderstanding

For many foreign manufacturers, the mistake is not intentionally ignoring FDA requirements.

It is assuming that because the company has completed FDA registration, the product is now “FDA registered” and therefore ready to sell.

Medical device regulation does not work that way.

The compliance status of the establishment and the regulatory status of the device itself are separate questions.

Before entering the U.S. market, manufacturers should understand both.

Preparing for U.S. Medical Device Importation

The most effective time to identify an FDA problem is before manufacturing a U.S.-specific production run, appointing distributors, or shipping commercial inventory.

A pre-market regulatory assessment can determine:

• Device classification

• Applicable product code and regulation

• Whether 510(k) clearance is required

• Whether an exemption may apply

• Establishment registration and listing obligations

• U.S. Agent requirements

• Initial Importer considerations

• Import and labeling readiness

For foreign medical device manufacturers, resolving these questions before shipment can reduce the risk of detention, refusal, and unnecessary disruption at the U.S. border.